104 related articles for article (PubMed ID: 25483979)
1. Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients.
Fadini GP; Rigato M; Boscari F; Cappellari R; Menegazzo L; Pilutti C; Iori E; Marescotti M; Plebani M; Albiero M; Avogaro A
Vascul Pharmacol; 2015; 67-69():21-9. PubMed ID: 25483979
[TBL] [Abstract][Full Text] [Related]
2. Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
Chiang KH; Cheng WL; Shih CM; Lin YW; Tsao NW; Kao YT; Lin CT; Wu SC; Huang CY; Lin FY
PLoS One; 2015; 10(8):e0136405. PubMed ID: 26309120
[TBL] [Abstract][Full Text] [Related]
3. Endothelial progenitor cells in diabetic patients with myocardial infarction - can statins improve their function?
António N; Soares A; Fernandes R; Soares F; Lopes A; Carvalheiro T; Paiva A; Providência LA; Gonçalves L; Fontes Ribeiro C
Eur J Pharmacol; 2014 Oct; 741():25-36. PubMed ID: 25066111
[TBL] [Abstract][Full Text] [Related]
4. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).
Eisen A; Leshem-Lev D; Yavin H; Orvin K; Mager A; Rechavia E; Bental T; Dadush O; Battler A; Kornowski R; Lev EI
Cardiovasc Drugs Ther; 2015 Apr; 29(2):129-35. PubMed ID: 25712416
[TBL] [Abstract][Full Text] [Related]
5. Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial infarction: a prospective observational study.
António N; Fernandes R; Soares A; Soares F; Lopes A; Carvalheiro T; Paiva A; Pêgo GM; Providência LA; Gonçalves L; Ribeiro CF
Eur J Clin Pharmacol; 2014 Oct; 70(10):1181-93. PubMed ID: 25048407
[TBL] [Abstract][Full Text] [Related]
6. Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study.
Briguori C; Quintavalle C; D'Alessio F; Donahue M; Roscigno G; De Micco F; Focaccio A; Visconti G; Del Vecchio L; Madonna R; De Caterina R; Condorelli G
Int J Cardiol; 2017 Oct; 244():112-118. PubMed ID: 28668399
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation.
Spiel AO; Mayr FB; Leitner JM; Firbas C; Sieghart W; Jilma B
Thromb Res; 2008; 123(1):108-13. PubMed ID: 18433844
[TBL] [Abstract][Full Text] [Related]
8. Effect of olmesartan on the levels of circulating endothelial progenitor cell after drug-eluting stent implantation in patients receiving statin therapy.
Aoki J; Kozuma K; Tanabe K; Tanimoto S; Nakajima Y; Yahagi K; Hashimoto T; Isshiki T; Hara K
J Cardiol; 2014 Dec; 64(6):435-40. PubMed ID: 24768407
[TBL] [Abstract][Full Text] [Related]
9. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ
Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
[TBL] [Abstract][Full Text] [Related]
11. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
12. Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension.
Raptis AE; Markakis KP; Mazioti MC; Ikonomidis I; Maratou EP; Vlahakos DV; Kotsifaki EE; Voumvourakis AN; Tsirogianni AG; Lambadiari VA; Lekakis JP; Raptis SA; Dimitriadis GD
Am J Hypertens; 2015 Jan; 28(1):22-9. PubMed ID: 24994608
[TBL] [Abstract][Full Text] [Related]
13. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
[TBL] [Abstract][Full Text] [Related]
14. Endothelial progenitor cell mobilization and increased intravascular nitric oxide in patients undergoing cardiac rehabilitation.
Paul JD; Powell TM; Thompson M; Benjamin M; Rodrigo M; Carlow A; Annavajjhala V; Shiva S; Dejam A; Gladwin MT; McCoy JP; Zalos G; Press B; Murphy M; Hill JM; Csako G; Waclawiw MA; Cannon RO
J Cardiopulm Rehabil Prev; 2007; 27(2):65-73. PubMed ID: 17558240
[TBL] [Abstract][Full Text] [Related]
15. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment.
Hristov M; Fach C; Becker C; Heussen N; Liehn EA; Blindt R; Hanrath P; Weber C
Atherosclerosis; 2007 Jun; 192(2):413-20. PubMed ID: 16837000
[TBL] [Abstract][Full Text] [Related]
16. Identical LDL-cholesterol lowering but non-identical effects on NF-κB activity: High dose simvastatin vs combination therapy with ezetimibe.
Rudofsky G; Reismann P; Groener JB; Djuric Z; Fleming T; Metzner C; Grafe IA; Bierhaus A; Nawroth PP
Atherosclerosis; 2012 Jul; 223(1):190-6. PubMed ID: 22633472
[TBL] [Abstract][Full Text] [Related]
17. Circulating monocyte chemotactic protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1) and angiogenin in type 2 diabetic patients treated with statins in low doses.
Dworacka M; Krzyżagórska E; Wesołowska A; Zharmakhanova G; Iskakova S; Dworacki G
Eur J Pharmacol; 2014 Oct; 740():474-9. PubMed ID: 24991787
[TBL] [Abstract][Full Text] [Related]
18. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
[TBL] [Abstract][Full Text] [Related]
19. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.
Pesaro AE; Serrano CV; Katz M; Marti L; Fernandes JL; Parra PR; Campos AH
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):447-52. PubMed ID: 23739650
[TBL] [Abstract][Full Text] [Related]
20. Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients.
Lins LC; França CN; Fonseca FA; Barbosa SP; Matos LN; Aguirre AC; Bianco HT; do Amaral JB; Izar MC
Cell Biochem Biophys; 2014 Sep; 70(1):687-96. PubMed ID: 24777811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
